Microalbumin/Creatinine Ratio

Other names: Microalb/Creat Ratio

Optimal result: 1 – 30 mg/g

An elevated Microalbumin/Creatinine Ratio (ACR) in urine signifies that there is an increased amount of albumin in the urine relative to creatinine. This condition, known as microalbuminuria, is an early marker of kidney damage, particularly in the context of diabetes and hypertension.

→ Diabetic Nephropathy: Elevated ACR is often an early indicator of diabetic nephropathy, a common complication of diabetes that affects the kidneys. Early detection through ACR allows for interventions that can slow the progression of kidney disease. 

→ Hypertension: High blood pressure can damage the blood vessels in the kidneys, leading to increased levels of albumin in the urine. Monitoring ACR can help manage and prevent further kidney damage in hypertensive patients.

→ Cardiovascular Risk: Elevated ACR is associated with an increased risk of cardiovascular diseases. This is because both kidney disease and cardiovascular disease share common risk factors and pathological mechanisms.

→ Chronic Kidney Disease (CKD): Persistent elevation in ACR can indicate chronic kidney disease. Detecting CKD at an early stage allows for better management and can help prevent or delay the progression to more severe kidney dysfunction.

Treatment and management strategies for elevated ACR focus on controlling underlying conditions such as diabetes and hypertension, using medications like ACE inhibitors or ARBs to protect kidney function, and adopting lifestyle changes such as maintaining a healthy diet, exercising regularly, and avoiding smoking.

By monitoring ACR levels, healthcare providers can assess the effectiveness of these interventions and make necessary adjustments to the treatment plan to protect kidney health and reduce associated risks.

The Microalbumin/Creatinine Ratio (ACR) is a critical diagnostic marker used primarily for evaluating kidney function, particularly in individuals at risk for kidney disease, such as those with diabetes or hypertension. This ratio is calculated by measuring the amount of albumin (a type of protein) and creatinine (a waste product) in a urine sample. Albumin is typically present in the blood and should be filtered and retained by healthy kidneys; however, when the kidneys are damaged, small amounts of albumin can leak into the urine, a condition known as microalbuminuria. Creatinine, produced at a relatively constant rate by muscle metabolism and excreted in the urine, serves as a benchmark for normalizing the amount of albumin excretion.

The Microalbumin/Creatinine Ratio (ACR) is a critical diagnostic marker used primarily for evaluating kidney function, particularly in individuals at risk for kidney disease, such as those with diabetes or hypertension. This ratio is calculated by measuring the amount of albumin (a type of protein) and creatinine (a waste product) in a urine sample. Albumin is typically present in the blood and should be filtered and retained by healthy kidneys; however, when the kidneys are damaged, small amounts of albumin can leak into the urine, a condition known as microalbuminuria. Creatinine, produced at a relatively constant rate by muscle metabolism and excreted in the urine, serves as a benchmark for normalizing the amount of albumin excretion. The ACR compensates for variations in urine concentration and provides a more accurate assessment of kidney function than measuring albumin alone. A normal ACR suggests healthy kidney function, whereas an elevated ACR indicates microalbuminuria and is one of the earliest signs of kidney damage. Regular monitoring of the ACR is particularly important in managing chronic conditions like diabetes, where maintaining optimal blood sugar levels can help prevent or delay the onset of kidney damage. This ratio is also useful in identifying individuals at increased risk for cardiovascular diseases, as microalbuminuria is associated with a higher risk of cardiovascular complications. The simplicity, non-invasiveness, and cost-effectiveness of the ACR test make it a valuable tool in both screening for early kidney disease and monitoring the progression and treatment efficacy in individuals with established kidney disease.

Microalbumin/Creatinine Ratio
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Microalbumin/Creatinine Ratio — 10,000+ markers explained
One Microalbumin/Creatinine Ratio result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro